Data / Form D filings / scPharmaceuticals Inc.
scPharmaceuticals Inc.: Form D filings
scPharmaceuticals Inc., a pharmaceuticals company in Lexington, MA, filed 5 Form D notices with the SEC between 2014 and 2017. The latest, on January 6, 2017, reports $47 million sold of a $47 million offering to 11 investors.
Find out what scPharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 131 Hartwell Avenue, Suite 215, Lexington, MA, 02421
- Phone
- (617) 517-0730
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1604950
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 6, 2017 | New notice | $46,962,788 | $46,962,788 | $0 | 11 | Dec 22, 2016 | sec.gov |
| Sep 6, 2016 | New notice | $10,000,000 | $4,000,000 | $6,000,000 | 3 | Aug 22, 2016 | sec.gov |
| Sep 6, 2016 | New notice | $8,183,797 | $8,183,797 | $0 | 15 | Aug 22, 2016 | sec.gov |
| Feb 4, 2016 | New notice | $7,500,000 | $3,600,000 | $3,900,000 | 12 | Jan 21, 2016 | sec.gov |
| Apr 7, 2014 | New notice | $17,053,016 | $9,053,016 | $8,000,000 | 9 | Mar 24, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dorothy Coleman | Director | |
| Abraham Ceesay | Executive Officer | |
| Troy Ignelzi | Executive Officer | |
| Kush Parmar | Director | |
| Leonard Schaeffer | Director | |
| Mette Agger | Director | |
| Pieter Muntendam | Executive Officer, Director | |
| Jack Khattar | Director | |
| Abhay Gandhi | Director | |
| Jonathan Silverstein | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 2, 2017 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what scPharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.